ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP5F1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP5I | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E | Mitochondrial proteins
| | | | | Expressed in all |
ATP7A | ATPase, Cu++ transporting, alpha polypeptide | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ATP9A | ATPase, class II, type 9A | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ATR | Ataxia telangiectasia and Rad3 related | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ATXN2L | Ataxin 2-like | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
AXIN1 | Axin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
BACE1 | Beta-site APP-cleaving enzyme 1 | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BBS4 | Bardet-Biedl syndrome 4 | Disease related genes
| | | | | Expressed in all |
BCAP31 | B-cell receptor-associated protein 31 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
BCL2L1 | BCL2-like 1 | Cancer-related genes Mitochondrial proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
BDP1 | B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB | | | | | | Expressed in all |
BMP2K | BMP2 inducible kinase | Enzymes
| | | | | Expressed in all |
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | Cancer-related genes Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BOC | BOC cell adhesion associated, oncogene regulated | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
BRSK1 | BR serine/threonine kinase 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
BST2 | Bone marrow stromal cell antigen 2 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
BTBD10 | BTB (POZ) domain containing 10 | | | | | | Expressed in all |
BTBD11 | BTB (POZ) domain containing 11 | | | | | | Group enriched |
BTN2A2 | Butyrophilin, subfamily 2, member A2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BTN3A3 | Butyrophilin, subfamily 3, member A3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BTNL8 | Butyrophilin-like 8 | Predicted membrane proteins
| | | | | Group enriched |
C15orf27 | Chromosome 15 open reading frame 27 | Predicted membrane proteins
| | | | | Tissue enhanced |
C19orf24 | Chromosome 19 open reading frame 24 | Predicted membrane proteins
| | | | | Expressed in all |
C1orf159 | Chromosome 1 open reading frame 159 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C1orf50 | Chromosome 1 open reading frame 50 | Predicted membrane proteins
| | | | | Expressed in all |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
C6orf47 | Chromosome 6 open reading frame 47 | Predicted membrane proteins
| | | | | Expressed in all |
C8orf58 | Chromosome 8 open reading frame 58 | | | | | | Expressed in all |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
CABLES2 | Cdk5 and Abl enzyme substrate 2 | Predicted membrane proteins
| | | | | Tissue enriched |
CADM1 | Cell adhesion molecule 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CALD1 | Caldesmon 1 | Cytoskeleton related proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CARD8 | Caspase recruitment domain family, member 8 | Predicted membrane proteins
| | | | | Expressed in all |
CASC4 | Cancer susceptibility candidate 4 | | | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CCDC127 | Coiled-coil domain containing 127 | | | | | | Mixed |
CCDC15 | Coiled-coil domain containing 15 | | | | | | Tissue enhanced |
CCDC155 | Coiled-coil domain containing 155 | Predicted membrane proteins
| | | | | Tissue enriched |
CCDC51 | Coiled-coil domain containing 51 | Predicted membrane proteins
| | | | | Expressed in all |
CCDC64 | Coiled-coil domain containing 64 | Predicted membrane proteins
| | | | | Tissue enhanced |
CCDC90B | Coiled-coil domain containing 90B | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
CCNC | Cyclin C | | | | | | Expressed in all |